Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence.
Sunassee ED, Deutsch RJ, D'Agostino VW, Castellano-Escuder P, Siebeneck EA, Ilkayeva O, Crouch BT, Madonna MC, Everitt J, Alvarez JV, Palmer GM, Hirschey MD, Ramanujam N.
Sunassee ED, et al. Among authors: deutsch rj.
Sci Adv. 2024 Apr 5;10(14):eadj7540. doi: 10.1126/sciadv.adj7540. Epub 2024 Apr 5.
Sci Adv. 2024.
PMID: 38579004
Free PMC article.